ArticleClinical pharmacokinetics2023

Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment.

Hengli Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.